ASAH1 and brain neoplasm: The mechanism involved in the regulation of ASAH1 may have been altered in the CD133+ GSCs, allowing it to be secreted into culture media (Figure 2D) or possibly into the interstitial tissues in case of an in vivo brain tumor.